Metin Kurtoglu insider trades
Open-market stock purchases and sales by Metin Kurtoglu, Chief Technology Officer at Cartesian Therapeutics, Inc, from SEC Form 4 filings since Nov 13, 2023.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- RNAC Cartesian Therapeutics, Inc: 14 sales, last Jan 6, 2025